Promoter holding
64.27%
AP
Actavis Pharma Development Centre Private Limited - Due diligence report
A 360° intelligence report on Actavis Pharma Development Centre Private Limited: trust score, financial health, credit view, compliance, dir…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Actavis Pharma Development Centre Private Limited — 360° Intelligence Report
Generated from MCA filings & public records90/100
Trust Score
Low Risk
Actavis Pharma Development Centre Private Limited is assessed as Low Risk with a Trust Score of 90/100. Actavis Pharma Development Centre Private Limited is an active private limited indian non-government company incorporated in 2006, operating in the Travel and Hospitality sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 19 Jul 2026 from the latest processed filings. Actavis Pharma Development Centre Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
82/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (3.00 cr) · 3 satisfied (24.85 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Idbi Bank Ltd. | 1 | 48.0 cr |
| The Hongkong And Shanghai Banking Corporation Limited | 1 | 48.0 cr |
| Idbi Bank Limited | 1 | 48.0 cr |
| Jp Morgan Chase Bank, N.A. | 1 | 48.0 cr |
Compliance Score: 82/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 auditor resignation(s) filed - latest: B S R & Co. LLP on 2017-09-19.
- Delayed payments to MSME suppliers disclosed (34 disclosure(s)).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SUNILKUMAR PATLOBA NAGARGOJE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHWETA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NISHANK BHARGAVA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VINOD NARAYAN SHETTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Shweta Agrawal | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 5 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Acatvis Holding Asis B.v.
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Acatvis Holding Asis B.v. | Holding Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 15.89 Lakh.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment86/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 3.00 cr already registered.
- Compliance record supports lending.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events25 Aug 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
11 Jul 2023
Director appointed
Shweta Agrawal (Company Secretary)
01 Jul 2023
Director appointed
SHWETA (Company Secretary)
17 Aug 2022
Director ceased
NISHANK BHARGAVA
Director ceased
VINOD NARAYAN SHETTY
23 Feb 2022
Director appointed
NISHANK BHARGAVA (Director)
31 Aug 2021
Director ceased
PRAMOD RAMCHANDRA GHORPADE
25 Aug 2021
Director appointed
VINOD NARAYAN SHETTY (Director)
28 Sep 2020
Director ceased
SUNILKUMAR PATLOBA NAGARGOJE
30 Nov 2019
Director ceased
GAURAV MATHUR
27 Nov 2019
Director appointed
SUNILKUMAR PATLOBA NAGARGOJE (Director)
10 Jul 2018
Director ceased
PRAMOD NARAYAN DALVI
21 Jul 2017
Charge created
Jp Morgan Chase Bank, N.A. - 3.00 cr
04 Nov 2016
Director ceased
PATRICK GERARD BRUNNER
10
Key Observations
Auto-generated from the data aboveRevenue declined 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Kvtek Power Systems Private Limited | U74220DL2005PTC135994 | New Delhi, Delhi, India |
| Pini India Private Limited | U45400DL2010FTC201575 | Delhi, Delhi, India |
| Volksara Techno Solutions Private Limited | U29253MH2007PTC170317 | Mumbai, Maharashtra, India |
| Iqs Engineering Solutions Private Limited | U29308PN2020PTC189353 | Pune, Maharashtra, India |
| Techflow Engineers | U28910MH2009PTC198086 | Navi Mumbai, Maharashtra, India |
| Steel Plantech India Private Limited | U74120WB2011FTC233104 | Kolkata, West Bengal, India |
| Lepton Projects Private Limited | U74120HR2008PTC111989 | Gurgaon, Haryana, India |
| Ampson Engineering Private Limited | U46692MH1985PTC036612 | Thane, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Actavis Pharma Development Centre Private Limited before audits and certifications: compliance score 82/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Actavis Pharma Development Centre Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Actavis Pharma Development Centre Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Actavis Pharma Development Centre Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Actavis Pharma Development Centre Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Actavis Pharma Development Centre Private Limited an active company?
Actavis Pharma Development Centre Private Limited has MCA status “Active” with a compliance score of 82/100 (Low Risk).
Is Actavis Pharma Development Centre Private Limited financially healthy?
Actavis Pharma Development Centre Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Actavis Pharma Development Centre Private Limited?
Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Actavis Pharma Development Centre Private Limited?
The ultimate holding entity is Acatvis Holding Asis B.v.. 5 active director(s) are on record.
Does Actavis Pharma Development Centre Private Limited have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.
Is Actavis Pharma Development Centre Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 82/100 (Low Risk).
Is it risky to lend to Actavis Pharma Development Centre Private Limited?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
